Filter
Exclude
Time range
-
Near
Drug delivery firm @DelSiTech has entered into a licensing deal with a global #pharma company. The deal grants a license to Delsitech's #silica-based delivery tech for the development and commercialisation of an injectable drug product. bit.ly/4d7sNvZ @TurkuBizRegion
446
Turkulainen DelSiTech on solminut satojen miljoonien euron lisenssisopimuksen globaalin lääkeyhtiön kanssa. Sopimuksessa yhtiö saa oikeudet käyttää DelSiTechin lääkeannosteluteknologiaa toistaiseksi julkaisemattoman lääkkeensä kehittämiseen. yle.fi/a/74-20090103?text=Su…
1
4
102
CEO Lasse Leino listed factors behind @DelSiTech success. These are two on them: solid scientific basis for the technology with continuous focus on improvment and focus on commercialisation&global business, not science. #InFLAMESCorporateCorner @UniTurku @AboAkademi
2
140
Tervetuloa huomenna keskiviikkona InFLAMES Corporate Corneriin! Welcome to InFLAMES Corporate Corner tomorrow! #networking #collaboration @spietikainen @VilleNiinisto @HerantisPharma @DelSiTech @akita_bio @LahesmaaGroup @matejoresic @ToivolaDiana @jarkko_koivunen
4
7
899
Terveysteknologia on aina ajankohtainen, hienoa DelSiTech! ”Lääkeannosteluteknologia- ja lääkekehitysyritys DelSiTech Oy on kerännyt 10 miljoonaa euroa pääomasijoituksia rahoituskierroksellaan.”. talouselama.fi/uutiset/suoma…

2
168
Finland’s DelSiTech secures €10 million to propel silica-based drug delivery technology into clinical development arcticstartup.com/delsitech-… via @ArcticStartup @DelSiTech #Funding #nordicmade #Finland #startups #deeptech #healtech #MedTech #pharmatech #Trending
1
3
363
Teknologiakampus Turku tarjoaa yrityksille TKI-seteliä yhteistyöhön turkulaisen korkeakoulun kanssa. Toistakymmentä yritystä on hyödyntänyt seteliä. Lue @UniTurku ja @DelSiTech yhteistyöstä ja TKI-setelin mahdollisuuksista! #turunkorkeakoulut utu.fi/fi/ajankohtaista/uuti…
1
7
854
2 Aug 2023
A Taft legal team including Michael Roberts, Abe Wehbi, Elisa Rhodes, and Rebecca Smith acted as legal counsel to DRW Venture Capital LLC in the company’s investment in DelsiTech. Read more here: bit.ly/3DFbceJ
2
194
🔊 STARTUP NEWS FROM...FINLAND! DelSiTech has been awarded a grant from the Bill & Melinda Gates Foundation to develop controlled and sustained-release injectables for prophylactic HIV vaccines. Read more ⬇ bit.ly/tna-nl-mar2023 #tnanews
2
483
DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine delsitech.com/delsitech-awar…

1
2
329
Drug delivery firm @delsitech has received a grant from the Bill & Melinda @gatesfoundation 👏 The #grant will be used to create long-acting injectable formulations that will gradually release the #HIV vaccine 💊 👉 ow.ly/g6Rs50NmFVA via @arcticstartup @TurkuBizRegion

2
8
978
#startupturku #deeptech @DelSiTech receives a grant from @gatesfoundation to create slow-release, long-acting injectable formulations for an HIV vaccine. By @arcticstartup arcticstartup.com/delsitech-… #NordicMade #LifeSciences

2
3
307
Finnish deep tech receives a grant to create slow-release, long-acting injectable formulations for an HIV vaccine arcticstartup.com/delsitech-… via @ArcticStartup @DelSiTech @gatesfoundation #Funding #grants #deeptech #HIV #biotech #nordicmade #Finland #Trending

3
3
423
Turkulainen lääkekehittäjä Delsitech sai jälleen rahoitusta Bill ja Miranda Gatesin säätiöltä – nyt tavoitteena on kehittää toimiva hiv-rokote ts.fi/uutiset/5937152?utm_me…

4
1,047
DelSiTech is looking for a highly motivated, goal-oriented CDO | Chief Development Officer. CDO provides leadership in in-house drug development as well as development services for customers. Read more>> inhunt.fi/inhunt_jobs/cdo-ch… #recruitment
4
US-based retinal disease biotech Iveric Bio has partnered with @DelSiTech to develop a sustained-release successor. The license agreement provides Iveric Bio with the right to use DelSiTech’s silica-based sustained release technology. ow.ly/n5mi50KcxOg via @FiercePharma

3
Iveric Bio and @DelSiTech announced an exclusive global license agreement providing @IvericBio with the right to develop and commercialize new formulations of #Zimura (avacincaptad pegol) using DelSiTech’s silica-based sustained release technology. bit.ly/3yoIYlk
1
2
Finland's @DelSiTech and China's @anticancerbio are collaborating on the development of silica-based long-acting controlled release treatments in oncology. ow.ly/kzNf30sk4ha via @TurkuBizRegion @DelSiTech @anticancerbio #goodnewsfromfinland #finland #oncology #delsitech

1
4
16 Nov 2021
@DelSiTech is committed to leveraging our technologies for the fight against #HIV. Join us, when DelSiTech's CEO, Dr. Lasse Leino will speak on the long-acting delivery of therapeutic antibodies at The Collaboration for AIDS Vaccine Discovery (CAVD) 16th annual meeting today.
2